Leadership Team

Michael Hoffman

Senior Director, Managed Care

Michael has over 15 years of pharmaceutical and diagnostic sales and managed care experience. Over his corporate career, Michael worked in a series of positions in sales, sales training, sales management, marketing, new product development, and managed care. The last 12 years have been exclusively in the Managed Care arena.

Before taking the Sr. Director of Managed Care position at Courtagen Life Sciences, Michael led the Reimbursement Department at Transgenomic, Inc., where he was Sr. Director of Managed Care and Reimbursement. Michael helped to lead the company’s effort to develop and implement a contracting strategy to increase access for the company’s genetic testing menu.

Michael has also worked at Cephalon and Daiichi Sankyo.

Michael received his BS Degree in History and Sociology from Northern Illinois University, DeKalb, IL.

Back to Top

Lori Emrick

Sr. Director, Marketing

Lori has over 20 years of commercial experience leading high performing teams in the life science industry.

Prior to joining Courtagen Life Sciences, she served as VP Sales and Commercial Strategy at Life Technologies, a global biotechnology company providing solutions for translational research, molecular medicine and diagnostics, cell biology, forensics, food safety and animal health.

Lori held multiple roles of increasing responsibility at Applied Biosystems and Life Technologies and has extensive experience with new product launches and delivering industry-leading growth in DNA sequencing and quantitative PCR technologies.

Lori received her B.S. in Biotechnology from Worcester Polytechnic Institute.

Back to Top

Julie Eggington, Ph.D

Sr. Director, Variant Sciences

Dr. Eggington joined Courtagen Life Sciences, Inc. as Senior Director of Variant Sciences in November 2013. Prior to joining Courtagen, Dr. Eggington built and directed Myriad Genetic Laboratories’ genetic Variant Classification Program. Under Julie’s leadership, Myriad’s program became the industry leading variant program in hereditary cancer genetic testing and a key market differentiator. Being the world’s first commercial diagnostic laboratory variant specialist, Dr. Eggington has been at the forefront of defining this rapidly growing scientific specialty. Dr. Eggington specializes in the initial classification of novel genetic variants, as well as the accurate reclassification of Variants of Uncertain Significance through optimized research methods. Tens of thousands of patients have been positively affected by the research programs overseen by Dr. Eggington. She is recognized as both a scientific leader and superb educator, frequently giving presentations at both national and international genetics meetings.

Dr. Eggington completed her postdoctoral training in a Howard Hughes Medical Institute laboratory at the University of Utah as a fellow for the American Foundation for Suicide Prevention. She received her Ph.D. in Biochemistry at the University of Wisconsin-Madison, and completed her M.S. in Biochemistry at the University of Utah. Julie received a B.S. with Honors from Brigham Young University in Biochemistry.

Back to Top

Doug Kennedy

Director, Non-Profit and Volunteer Outreach

Doug Kennedy joined the Courtagen Life Sciences team as Director, Non-Profit and Volunteer Outreach after more than twenty years of experience in providing humanitarian aid in impoverished regions around the world. His work in Honolulu included developing the New Hope Relief program and leading more than 200 medical, first response, and community development outreach programs in Southeast Asia and the South Pacific. Following the Indian Ocean tsunami in 2004, his relief efforts included working as a producer on the film “The Third Wave”, which was screened in the first ever Presidential Jury Screening in the 2008 Cannes Film Festival and resulted in the development of CTEC – a community based tsunami warning center in Peraliya, Sri Lanka.

In 2009, he joined the staff of the Happy Hearts Fund as the Director of Volunteers where he developed multiple platforms for individuals and groups to participate in providing second wave response efforts following natural disasters including, nationwide fundraising teams to benefit the construction of schools, a New York City based intern program that played an active role with the Clinton Global Initiative, an online education program to equip students around the world in response to natural disasters, and traveled extensively to impacted regions for the purpose of nurturing the relationship between HHF and donors.

He currently resides in New York and Honolulu and continues as a consultant for non-profit organizations in volunteer development. At the core of all he does is his goal to see people realize the joy found when they apply their skills and passions to meet the needs of others.

Back to Top

Daniel Walsh

Director of Sales

Dan joined Courtagen Life Sciences as an Account Manager for the Northeast in 2012, and was promoted to Director of Sales in 2014.  Dan began his sales career with Pfizer Pharmaceuticals. While at Pfizer, Dan was recognized with numerous sales awards including "Regional Performance Fund" winner, "Conventional Wisdom Award" winner, and "Excellence in Action" winner. Dan achieved a number one rank among his sales peers due to his outstanding product knowledge, sales skills training and evaluation. Whether selling pharmaceuticals or financial and insurance products Dan has exceeded his goals consistently.

Previously, Dan served in the US Navy as a pilot for 9 years on active duty and 11 years in the reserves. Dan served on every continent in the world and retired as a Commander in June of 2008. While serving his country, Dan was a patrol plane commander and instructor pilot. He also held several positions within his squadrons while serving from Safety Officer and Training Officer to Operations Officer in charge of millions of dollars in operational assets in the US and overseas. Dan also spent several years as an airline pilot, flying internationally for TWA and American Airlines.

Dan is a graduate of The University of Notre Dame where he majored in International Relations and minored in Business. Dan received his commission in the US Navy through the Navy Reserve Officer Training Corp program.

Back to Top

Cory Lance

Director of Sales

Cory has over 15 years of sales experience in the medical arena with 12 of those years in the laboratory space. Prior to joining Courtagen, Cory was the National Sales Manager for the Neurology Business unit of Transgenomic where he successfully managed a sales team selling mitochondrial and epilepsy genetic testing testing to geneticists and pediatric neurologists. Previously, Cory was with IMPAC Medical Systems, where he was the District Sales Manager overseeing the sales of Anatomic Pathology software to Academic Medical Centers, Children's Hospitals, Community Hospitals, and Reference Labs. Cory also spent time in Pathology at both the Cleveland Clinic and Ohio State University Medical Center procuring tissue for researchers across North America.

Cory received his BS Degree in Molecular Biology from The Ohio State University, Columbus, Ohio.

Back to Top

Jason Warner, Ph.D.

Director, Bioinformatics

Prior to joining Courtagen, Jason was Head of Bioinformatics at RainDance Technologies. At RainDance, Jason developed workflows and pipelines for next-gen sequencing analysis and primer design, as well as optimized assays for the RDT1000 target enrichment platform. Prior to RainDance, Jason contributed to the development of the SOLiD next-gen sequencing platform at Applied Biosystems.

Jason completed his postdoctoral training in bioinformatics and technology development at Harvard Medical School. Jason completed his PhD in Molecular and Cellular Physiology from Tufts University School of Medicine and he holds a BA in Biological Sciences from Cornell University.

Back To Top

Timothy Olcott, MBA

Director, Operations

Tim is a Co-Founder of Courtagen Life Sciences. Previously, he worked for Agencourt Bioscience from its 2001 inception through its acquisition by Beckman Coulter in 2006, leaving in 2007 to pursue an MBA. Throughout Agencourt’s rapid growth, Tim worked in manufacturing services. His responsibilities included purchasing, inventory planning and control, quality management, facilities management, and new product development. Most notably, Tim led a task force that implemented lean manufacturing practices in the laboratory, maintaining a low cost structure to drive margins and other key indicators. Tim also served on the New Product Development committee at Agencourt and managed the release of several successful product launches.

Tim earned his undergraduate degree in Business/Finance at the University of Colorado at Boulder. He left Agencourt in 2007, a year after the merger with Beckman Coulter, to pursue an MBA at Babson College. While studying at the F.W. Olin Graduate School of Business at Babson College, he worked as an intern for the Boston Harbor Angel group coordinating deal screening and due diligence activities. Tim graduated from Babson in June of 2009.

Back to Top

View Site in Mobile | Classic
Share by: